Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Overview | 6 | 1 |
| Therapeutics Development | 7 | 3 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Products under Development by Stage of Development | 7 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Products under Development by Therapy Area | 8 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Products under Development by Indication | 9 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Pipeline Products Glance | 10 | 2 |
| Late Stage Products | 10 | 1 |
| Early Stage Products | 11 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Products under Development by Companies | 12 | 2 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Therapeutics Assessment | 14 | 4 |
| Assessment by Monotherapy/Combination Products | 14 | 1 |
| Assessment by Mechanism of Action | 15 | 1 |
| Assessment by Route of Administration | 16 | 1 |
| Assessment by Molecule Type | 17 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Companies Involved in Therapeutics Development | 18 | 7 |
| ArQule, Inc. | 18 | 1 |
| Astex Pharmaceuticals, Inc. | 19 | 1 |
| Eddingpharm | 20 | 1 |
| Merck KGaA | 21 | 1 |
| PharmAust Limited | 22 | 1 |
| Phoenix Biotechnology, Inc. | 23 | 1 |
| Sentinel Oncology Limited | 24 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Drug Profiles | 25 | 9 |
| AT-13148 Drug Profile | 25 | 2 |
| EDP-317 Drug Profile | 27 | 1 |
| M-2698 Drug Profile | 28 | 1 |
| monepantel Drug Profile | 29 | 1 |
| PBI-05204 Drug Profile | 30 | 2 |
| Small Molecule To Inhibit S6K1 For Breast Cancer Drug Profile | 32 | 1 |
| Small Molecules to Inhibit S6K for Cancer Drug Profile | 33 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Dormant Projects | 34 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Discontinued Products | 35 | 1 |
| 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Featured News &Press Releases | 36 | 5 |
| Jan 29, 2016: PharmAust Limited Announced Quarterly Report &Company Update For the period ended 31 December 2015 | 36 | 1 |
| Nov 26, 2015: PharmAust Appoints GenScript to Complete Further Pre-Clinical Validation for Phase II Trial | 37 | 1 |
| Jan 17, 2013: Cancer Research UK And Cancer Research Technology Launches Phase I Clinical Trial With AT13148 To Treat Several Cancer Types | 37 | 1 |
| Jan 16, 2013: Astex Pharma Announces Cancer Research UK And Cancer Research Technology Initiate AT13148 Clinical Trial To Treat Several Cancer Types | 38 | 1 |
| Jul 10, 2012: Experimental Drug Could Treat Different Cancers, New Research Says | 39 | 1 |
| Jan 22, 2010: ACT BIOTECH Announces FDA Acceptance Of IND For ACTB1003, A First-in-Class Anti-Cancer Therapeutic | 40 | 1 |
| Oct 18, 2007: Astex Drug Candidates To Be Featured At The 2007 AACR-NCI-EORTC International Conference | 40 | 1 |
| Appendix | 41 | 2 |
| Methodology | 41 | 1 |
| Coverage | 41 | 1 |
| Secondary Research | 41 | 1 |
| Primary Research | 41 | 1 |
| Expert Panel Validation | 41 | 1 |
| Contact Us | 41 | 1 |
| Disclaimer | 42 | 1 |